STAT Plus: Seres announces positive late-stage results for its microbe-based drug
RUBY WALLAU FOR STAT
Seres is the third company this year to announce positive results from clinical trials for microbe-based drugs to treat C. difficile infections.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario